Oslo, Norway, 22 July 2026: Photocure ASA (Photocure, PHO: OSE) will announce
the second quarter 2026 financial results on Wednesday 29 July 2026 at 08:00
CEST and will present a live webcast at 14:00 CEST the same day.
The quarterly report and presentation will be published at 08:00 CEST and will
be publicly available at www.photocure.com.
The investor presentation will be streamed live and hosted by Dan Schneider,
CEO, Priyam Shah, VP of Investor Relations and Dick Peters, VP Finance & IT. The
presentation will be held in English and questions can be submitted throughout
the event. The presentation is scheduled to conclude at 14:45 CEST.
The streaming event is available through https://qcnl.tv/p/FjEYoKWacAN
-FYhADjmt6A (https://eur01.safelinks.protection.outlook.com/?url=https%3A%2F%2Fq
c
nl.tv%2Fp%2FFjEYoKWacAN
-FYhADjmt6A&data=05%7C02%7Cdick.peters%40photocure.com%7C366a74cd672b4c53767808d
e
e3d9632c%7C0986794f1d6f488980bd853c0715d3c1%7C0%7C0%7C639198719996017727%7CUnkno
w
n%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFO
I
joiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=3ijImqB220g4%2FJ7Jwh2lk1Hpjg%2FOe
N
jujrE2%2B8SVS64%3D&reserved=0)
For further information, please contact:
Photocure
Priyam Shah
Vice President of Investor Relations
Tel: +17176815072
Email: priyam.shah@photocure.com
Media enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com/news
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.
ant to section 5\
-12 of the Norwegian Securities Trading Act.\